ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2009;87:1161-1169. doi:10.1016/j.athoracsur.2009.01.016
© 2009 The Society of Thoracic Surgeons

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philip J. Hess, Jr
P. Kent Harman
Charles T. Klodell
Thomas M. Beaver
Marco T. Bologna
Peter Mikhail
Curtis G. Tribble
Tomas D. Martin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hess, P. J.
Right arrow Articles by Martin, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hess, P. J., Jr
Right arrow Articles by Martin, T. D.
Related Collections
Right arrow Great vessels


Original Articles: Adult Cardiac

Early Outcomes Using the Florida Sleeve Repair for Correction of Aortic Insufficiency due to Root Aneurysms

Philip J. Hess, Jr, MD*, P. Kent Harman, MD, Charles T. Klodell, MD, Thomas M. Beaver, MD, MPH, Marco T. Bologna, MD, Peter Mikhail, MD, Curtis G. Tribble, MD, Tomas D. Martin, MD

Division of Thoracic and Cardiovascular Surgery, University of Florida, College of Medicine, Gainesville, Florida

Accepted for publication January 7, 2009.

* Address correspondence to Dr Hess, Jr, Division of Thoracic and Cardiovascular Surgery, University of Florida, PO Box 100286, Gainesville, FL 32610 (Email: hesspj{at}surgery.ufl.edu).

Presented at the Fifty-fifth Annual Meeting of the Southern Thoracic Surgical Association, Austin, TX, Nov 5–8, 2008.


Drs Martin and Hess disclose that they have received a speaker's honoraria from Terumo Cardiovascular Systems. No author has stock ownership or a financial conflict of interest.

 

    Abstract
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 Discussion
 References
 
Background: The Florida sleeve procedure is a simplified valve-sparing technique for repair of functional type I aortic insufficiency associated with root aneurysms. Midterm outcomes are reported, including standard echocardiographic measurements.

Methods: The study included all patients undergoing the Florida sleeve procedure who had at least 2 years of postoperative echocardiographic follow-up. Data were acquired preoperatively and postoperatively at 1 week and 1, 2, and 3 years. Measurements analyzed included left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), and degree of aortic insufficiency.

Results: Complete echocardiographic data for a mean 32 ± 6.3 months after repair were available for 18 patients. Mean LVEDD decreased from 51.6 ± 7.4 to 49.7 ± 6.3 mm at 1 week (p = 0.05) and 47.1 ± 6.3 mm at 1 year (p = 0.008), and remained unchanged at 47.2 ± 6.6 and 47.1 ± 5.0 mm at 2 and 3 years. Mean LVESD decreased from 35.2 ± 7.6 to 32.9 ± 7.0 mm at 1 week (p = 0.002) and 30.7 ± 5.6 mm at 1 year (p < 0.001), and remained unchanged at 30.9 ± 6.2 and 31.7 ± 4.9 mm after 2 and 3 years. The mean grade of aortic insufficiency decreased from 2.61 ± 0.78 to 1.39 ± 0.85 mm at 1 week (p < 0.001) and remained 1.39 ± 0.84 mm at 1 year. Aortic insufficiency increased to 1.72 ± 0.89 (p = 0.03) at 2 years and decreased to 1.67 ± 0.50 (p = 0.59, from 1 week postoperatively) at 3 years.

Conclusions: The sustained reduction of left ventricular dimensions 3 years after operation suggests the Florida sleeve procedure is a durable valve repair. A minor increase in the degree of aortic insufficiency warrants close follow-up, but the absence of an increase of LVEDD supports continued use of the procedure in closely studied series.

Aortic insufficiency (AI) associated with root aneurysms is usually caused by simple lateral displacement of the leaflets. When root dilatation pulls otherwise normal leaflets from the luminal midpoint, central jet AI ensues and the functional classification is type I. The diagnostic accuracy of echocardiography for type I regurgitant lesions exceeds 90%, and repairability of the functional type I regurgitant valve associated with root aneurysms approaches 100% [1]. The excellent midterm to long-term durability of repairs of the type I valve leak during root aneurysm resection is well documented [1–5].

The measurements for assessment of long-term durability after repair of incompetent aortic valves are similar to the preoperative evaluation, and ideally include echocardiographic determination of left ventricular dimensions as well as systolic function and degree of AI [6, 7]. Modern valve-sparing procedures for AI associated with root enlargement require resection of the dilated sinuses, followed by remodeling of the aortic root or reimplantation of the aortic valve inside a Dacron (Dupont, Wilmington, DE) tube graft. Cautionary reports of progressive sinus enlargement in some patients after root remodeling procedures have encouraged more interest in valve reimplantation techniques where circumferential support of the root is assured [8, 9].

We previously described a simplified reimplantation technique in which the sinuses are not resected and the coronary artery origins are left intact [10]. Stability of the annulus, sinuses, and sinotubular junction is accomplished using a periaortic Dacron tube conduit as a sleeve. Reasonable concerns about this external tube or sleeve repair include long-term durability of the valve and dimensional stability of the reinforced root. To assess these concerns, we retrospectively reviewed preoperative and postoperative echocardiographic measurements customarily used to monitor AI; specifically, left ventricular and aortic dimensions, grade of AI, and left ventricular ejection fraction (LVEF).

The purpose of the study was to evaluate the durability of the aortic valve and dimensional stability of the root after the Florida sleeve repair for functional type I AI associated with aortic root aneurysms.


    Patients and Methods
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 Discussion
 References
 
Patients
Institutional Review Board approval was obtained for the retrospective review of the records of the first 45 consecutive patients undergoing the Florida sleeve procedure for repair of AI associated with aortic root aneurysms from May 2002 to May 2006. The need for patient consent for the study was waived. Selection of the sleeve procedure over other repairs was surgeon preference. Randomization was not part of the protocol, and a comparable temporally related cohort receiving other root procedures was not studied. The purpose of the study was to evaluate the durability of the aortic valve repair; therefore, only patients with a minimum of 2 years of transthoracic echocardiographic (TTE) follow-up were included.

Valves with normal or mildly attenuated leaflets were accepted for the sleeve procedure, but valves with prolapsed, fenestrated, or otherwise damaged leaflets underwent valve replacement and were not included in the study. Some reports of successful valve repair during root aneurysm resections have included valves with leaflet prolapse or fenestration (type 2 lesion) [11, 12], but during this developmental stage of the sleeve procedure, valves with type 2 leaflet pathology were specifically excluded. All incompetent valves repaired in this series were functional type 1; that is, aortic insufficiency due to enlargement of the aortic root with normal leaflets [1, 13].

Mathematic models to predict the ideal diameter of the annuloplasty have been exhaustively pursued by others [14], but with the sleeve procedure, the final annular diameter is determined almost exclusively by the point of reduction at which good leaflet coaptation occurs [10]. This is a visual, qualitative judgment, and we have not developed a formula for graft size related to ideal annulus size. Sleeve graft diameter is not based on cusp height, but rather the observation of suitable free edge contact of the leaflets. The sleeve graft size is usually about 7 to 10 mm larger than the diameter of the reduced annulus. The dilated sinuses occasionally had to be "stuffed" into the original style tube grafts, but conversion to the Valsalva graft (Vascutek Ltd, Renfrewshire, United Kingdom) has minimized this problem.

Procedure
Typically, after placement of the subannular horizontal mattress sutures, an annulus reduction suitable for leaflet coaptation and valve competence is estimated. A cylindrical Hegar dilator (Jarit Instruments, Hawthorne, NY) is placed through the valve to maintain the same annulus size reduction as the sleeve graft is then sized and seated. The subannular anchor sutures are delivered outward through the sleeve graft. The presized dilator prevents annular narrowing while the sutures are tied. Tying each subannular mattress suture produces about 1 mm of additional annulus reduction. With the original technique using 10 to 12 subannular sutures, annulus constriction was a major concern and the indwelling dilator was paramount. The modification using a total of only 3 to 4 subannular sutures greatly decreases the likelihood of annular constriction, but it is still imperative to avoid annular narrowing (Fig 1). In smaller roots, a Hegar dilator is placed intermittently through the distal suture line to avoid narrowing the repair at the sinotubular junction (STJ).


Figure 1
View larger version (90K):
[in this window]
[in a new window]

 
Fig 1. The 4 subannular anchoring sutures are placed in the same horizontal plane, 2 to 3 mm below the lowest point of the center of the leaflets; 3 are in line with the commissures, and a fourth is placed under the noncoronary cusp. The left coronary artery keyhole is cut after the sleeve is temporarily seated. The slits in the graft below the coronary keyholes are repaired after the sleeve is seated.

 
Once the sleeve graft is seated over the root, the slits in the graft below the coronary keyholes are repaired with simple sutures. The dissection under the left main coronary artery may infrequently be tedious in the presence of inflammatory changes around chronic aneurysms, but closure of the slits in the Dacron graft below the coronary keyholes assures concentric containment of the most proximal root. When the suture lines are placed at the distal end of the sleeve (Fig 2), an important technical point is the orientation of each commissural post in a similarly reduced equidistant position from the other posts on the aortic circumference as observed before root reduction. Excessive reduction of one intercommissural distance compared with another may produce prolapse or misalignment of leaflet contact surfaces.


Figure 2
View larger version (95K):
[in this window]
[in a new window]

 
Fig 2. The running horizontal mattress suture both suspends the aorta and orients the posts of the commissures. Redundant aortic wall at the sinotubular junction should be imbricated with small pleats using multiple, closely spaced bites of the running anastomotic suture.

 
Pledgeted horizontal mattress sutures placed through the top of the commissural posts may be used to anchor a commissure superiorly. Vertical hitching of the commissures to the Dacron sleeve is occasionally performed to make minor changes in the vertical level of the free edge of a leaflet and to help suspend the valve, but more elaborate valvuloplasty techniques have not been necessary with type I lesions. With a STJ diameter exceeding 45 mm, redundant aortic wall at the STJ may need to be pleated. This is accomplished using multiple, closely spaced bites when sewing the 2 running suture lines at the distal end of the graft, as demonstrated in Figure 2. Inadvertent creation of large eccentric folds in the sinus walls are avoided. The completed repair is seen in Figure 3.


Figure 3
View larger version (78K):
[in this window]
[in a new window]

 
Fig 3. Finished repair.

 
As is common in studies during the development of a new procedure, some technical steps of the sleeve repair have changed. The basic operation has always entailed periaortic Dacron graft support of the annulus, root, and sinotubular junction [10], but modifications have evolved. The original technique of placing numerous subannular mattress sutures to anchor the proximal end of the sleeve graft probably contributed to heart block in 3 patients early in the series, but after reducing the number of anchor sutures to 3 to 4 and widely avoiding the septal area, heart block has not occurred. The transverse plane for the placement of the subannular anchoring sutures remains 2 to 3 mm below the nadir of the center of each leaflet. The first 3 mattress sutures are placed directly in a vertical line with each commissure, and a fourth mattress suture is placed in the same plane, 2 to 3 mm beneath the center of the noncoronary cusp. Others have observed distal migration of periaortic Dacron wraps along the noncoronary sinus region of the ascending aorta [15], and this additional subannular suture is advised.

The proximal repair is firmly anchored by these 4 subannular sutures, and no evidence of sinus bulging below the graft has been observed on echo, computed tomography (CT) scan, or magnetic resonance imaging. No graft migration has occurred, and no coronary artery kinking, distortion, or aneurysm formation has been observed at the coronary keyholes in the graft. With bicuspid valves, a subannular suture is placed under each of the 2 commissures, and 2 additional subannular sutures are placed roughly opposite each other half way between the commissure sutures. Few bicuspid valves were used for this procedure, having only trace or mild insufficiency, and no prolapse occurred after annulus reduction.

Only 2 patients in this consecutive series received Valsalva grafts, although we now use this graft almost exclusively. Anatomic and theoretic factors involved in the change to the Valsalva graft are discussed in the "Comment" section.

Echocardiographic Measurements
All patients had typical echocardiographic central jet AI. Echo measurements included grade of aortic valve insufficiency on a scale of 0 to 4 (0 = none, 1 = trace, 2 = mild, 3 = moderate, 4 = severe), LVEF, LV end-systolic (LVESD) and end-diastolic diameter (LVEDD), and STJ diameter. The maximum aortic root size at the sinuses was typically 15 to 25 mm larger than the STJ diameter on preoperative CT scan, but the TTE measurement of the root diameter at the sinuses was often problematic due to an inadequate ultrasound window or inability to obtain satisfactory transverse root orientation. Therefore, root diameter at the sinuses was not considered a reproducible or reliable dimension and STJ was measured instead.

TTEs were performed or evaluated by University of Florida cardiology faculty members not involved in the study. All patients underwent TTE a mean of 13 days (range, 0 to 34 days) preoperatively and 6.8 days (range, 4 to 9 days) postoperatively. The timing of annual TTE examinations was defined as annually ± 45 days from the date of the operation. New York Heart Association functional class is a late and subjective indicator of worsening AI, consistently lagging changes in LV dimensions, and was not used in this study.

Statistical Analysis
Echocardiographic data were retrieved preoperatively and at 1 week and 1, 2, and 3 years postoperatively. Analysis of each data point for statistical significance was made against the immediately preceding time point, except where otherwise stated. A paired t test was used to separate means between the respective data points, significance was set at p ≤ 0.05. Categoric data were expressed as percentages, and the Fisher exact or {chi}2 test was used as appropriate for comparison of groups. All statistical analyses were done using SAS 9.1.3 software (SAS Institute; Cary, NC) and reported as mean and standard deviation.


    Results
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 Discussion
 References
 
The first 45 consecutive patients undergoing the Florida sleeve repair were the cohort group and included 6 emergency type A dissections, 2 chronic type A dissections, classic annuloaortic ectasia, and chronic root/ascending aortic aneurysms. There were 3 operative deaths (6.7%) and 4 late deaths in the cohort (Table 1). No operative (30-day or any death without hospital discharge) or late deaths were caused by aortic valve failure, ostial or proximal coronary artery complications, or recurrent ascending aortic pathology. No reparatory or late cardiac operations were performed.


View this table:
[in this window]
[in a new window]

 
Table 1 Mortality in Sleeve Cohort (N = 45)
 
Complete TTE follow-up data for at least 2 years were available for 18 patients, and this became the study group upon which this report focuses. The study group included 6 women with Marfan syndrome defined by medical record (Gent criteria not confirmed [16]) and 2 with a bicuspid valve. Mean follow-up for the study group was 32 ± 6.3 months (range, 24 to 38 months). No late deaths or reoperations occurred in the study group. Patient characteristics and perioperative complications for the cohort and study groups are listed in Tables 2 and 3. Go LV dimensions and AI are expressed in Figure 4.


View this table:
[in this window]
[in a new window]

 
Table 2 Comparison of Total Cohort With Study Group
 

View this table:
[in this window]
[in a new window]

 
Table 3 Operative Complications (30 Day)
 

Figure 4
View larger version (17K):
[in this window]
[in a new window]

 
Fig 4. Echocardiographic data points (mean and standard deviation) for left ventricular end-diastolic diameter (LVEDD, black line), left ventricular end-systolic diameter (LVESD, gray line), and aortic insufficiency (AI, dashed line: preoperatively, 1 week postoperatively, and 1, 2, and 3 years after repair). ({ddagger}LVEDD: preoperatively to 1 week [p = 0.05] and 1 week to 1 year [p = 0.008]. {dagger}LVESD: preoperatively to 1 week [p = 0.002] and 1 week to 1 year [p < 0.001]. {delta}AI: preoperatively to 1 week [p < 0.001], and 1 year to 2 years [p = 0.03]. One week to 3 years [p = 0.594].)

 
A comparison of preoperative and postoperative TTE measurements observed that:
• LVEDD decreased from 51.6 ± 7.4 mm preoperatively to 49.7 ± 6.3 mm at 1 week (p = 0.05) and 47.1 ± 6.3 mm at 1 year (p < 0.001). LVEDD remained unchanged thereafter at 47.2 ± 6.6 mm at 2 years (p = 0.91) and 47.1 ± 5.0 mm at 3 years (p = 0.33).
LVESD decreased from 35.2 ± 7.6 mm preoperatively to 32.9 ± 7.0 mm at 1 week (p = 0.002) and 30.7 ± 5.6 mm at 1 year (p < 0.001). LVESD remained unchanged thereafter at 30.9 ± 6.7 mm at 2 years (p = 0.81) and 31.7 ± 4.9 mm at 3 years (p = 0.40).
• AI decreased from a grade of 2.61 ± 0.78 preoperatively to 1.39 ± 0.85 at 1 week (p < 0.001) and was unchanged at 1.39 ± 0.84 at 1 year (p = 0.82). AI increased to 1.72 ± 0.89 at 2 years (p = 0.03) and decreased slightly to a level unchanged from 1 week postoperatively at 1.67 ± 0.50 at 3 years (p = 0.59).
• The STJ diameter was surgically reduced from 47.4 ± 6.1 mm preoperatively to 36.9 ± 5.9 mm at 1 week (p < 0.001). STJ diameter remained unchanged thereafter at 36.5 ± 3.9 mm at 1 year (p = 0.68), 36.0 ± 4.2 mm at 2 years (p = 0.37), and 36.5 ± 3.4 mm at 3 years (p = 0.70).
• LVEF was unchanged throughout the study at 0.57 ± 0.053 preoperatively and 0.56 ± 0.057 at 1 week (p = 0.29), 0.59 ± 0.067 at 1 year (p = 0.12), 0.59 ± 0.069 (p = 0.82) at 2 years, and 0.58 ± 0.052 at 3 years (p = 0.39) postoperatively (Table 4).
The distribution of Dacron graft sizes used for the sleeve repairs is shown in Figure 5.


View this table:
[in this window]
[in a new window]

 
Table 4 Ejection Fraction and Sinotubular Junction Diameter
 

Figure 5
View larger version (18K):
[in this window]
[in a new window]

 
Fig 5. Distribution of sleeve graft sizes in the study and cohort groups.

 
In compliance with standard valve reporting guidelines [17, 18] and in addition to the operative complications listed in Table 3, no repaired aortic valve developed structural deterioration after sleeve repair, and no nonstructural dysfunction, thrombosis, or operated-valve endocarditis occurred in the total sleeve cohort of 45 patients. No peripheral embolic events or bleeding complications occurred after hospital discharge. No aortic stenosis or LV outflow tract obstruction was observed during follow-up in this series.

The 4 late deaths were not caused by valve failure, ascending aortic disruption, or proximal coronary artery distortion. No patient has required reoperation or reintervention on the aortic valve, proximal coronary arteries, or ascending aorta. Two patients in the cohort were unavailable for follow-up after 12 and 13 months respectively. Records show that both are alive, but additional data could not be obtained. No study group patient has been lost to follow-up. Of 18 patients in the study group, 18 were at risk at 2 years and 10 at 3 years. Kaplan-Meier curves were not constructed because the follow-up period was too short to be meaningful.

Antithrombotic management was aspirin 81 mg daily in all patients. Anticoagulation with unfractionated heparin, enoxaparin, or warfarin was not used, including patients with temporary in-hospital postoperative atrial fibrillation.


    Comment
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 Discussion
 References
 
Main Findings
This study confirms the early durability of aortic root reconstruction and valve repair by simple root reduction using a periaortic Dacron sleeve graft for the treatment of functional type I AI due to aortic root aneurysm. The sleeved aortic root is dimensionally stable after 32 ± 6.3 months, and the valvuloplasty is acceptably competent, as evidenced by preserved LV geometry. Mean follow-up of 32 months is at best midterm and short of the reported 7- to 10-year durability of current valve reimplantation procedures, but the sleeve repair offers a considerably less complicated alternative and merits further evaluation.

Historically, the bioprosthetic valve conduit has been a widely used solution for avoiding anticoagulation while effecting a reliable reconstruction of the root and ascending aorta. The predictable durability of modern bioprosthetic valves compared with repaired aortic valves is attractive, but the inevitable valve redo operation may be formidable. For this reason, the tissue valve conduit reconstruction has been largely replaced by aortic root remodeling or valve reimplantation procedures [3, 4]. Growing evidence of sinus expansion after root remodeling procedures has made valve reimplantation the more appealing repair, particularly after de Oliveira and colleagues [8] observed in Marfan patients that 96% remained free of AI exceeding 2+ a mean of 8 years after a reimplantation valve-sparing procedure, but only 71% were free of AI exceeding 2+ after root remodeling.

Expansion of the residual sinus wall may be unique to the Marfan population, but the sinuses rather than the leaflets appear to be the more unpredictable component in root remodeling procedures. Like other reimplantation techniques, with the sleeve repair the entire root resides within an unyielding conduit, avoiding unpredictable sinus expansion or speculation about the expression of a patient's genotype for connective tissue disorders. Dimensional stability of the sleeved root is confirmed by the unchanged STJ diameter from 1 week to 3 years (p = 0.70). Further, the sleeve accomplishes a stable repair of the aortic root and also avoids the need for radical sinus resection and coronary artery transfer. Aortic valve reoperations after some root reconstruction techniques may be complicated by numerous suture lines from the Dacron graft to the aorta, but although no Florida sleeve patients have undergone reoperation yet, the dissection inside the root should not be hampered by exposed Dacron, and the annulus should be large and fully intact.

Reduction of AI grade from a mean of 2.61 ± 0.78 preoperatively to 1.39 ± 0.85 postoperatively was observed after repair, and AI remained unchanged at 1.39 ± 0.84 after 1 year (p = 0.82). AI increased significantly to 1.72 ± 0.89 at 2 years (p = 0.03) and then decreased to 1.66 ± 0.50 at 3 years (p = 0.34). The AI grade at 3 years was not statistically different from 1 week postoperatively (p = 0.59), but the trend toward increasing AI is concerning and not easily explained by factors such as minor increases in blood pressure with increased age or decreased pulse rate after β-blocker manipulation related to the former.

LVEDD is the a well accepted early indicator of worsening AI [6, 19], and the sustained reduction of LVEDD for 32 ± 6.3 months supports the durability of the valve repair. LVESD also remained stable 32 months after the sleeve repair, and although not a dimension affected early in the course of worsening AI, it is a sensitive indicator of LV systolic dysfunction and good corroborating evidence of acceptable aortic valve competence [6, 19].

Technical Considerations
David and colleagues [20] have described the preservation of leaflets from roots up to 50 mm using sinus resection and reimplantation techniques. We have found the native leaflets of roots up to 65 mm to be predictably suitable for sleeve repair. The sleeve repair in larger roots requires considerable patient selection, because the leaflets may be attenuated and less suitable for salvage using simple annulus and STJ reduction.

Significant transverse expansion of the sleeve grafts was not observed after the first postoperative week in this series, but early dilation remains a concern. The expansion of woven Dacron tube grafts after thoracic aortic replacement has been extensively studied and recently reported by Etz and colleagues [21] in a retrospective review of CT scans of 547 patients in whom thoracic aortic grafts were placed during a 20-year period at a single institution. In the ascending aorta, rapid expansion averaging 17% occurred within 7 days of implantation, but thereafter, expansion averaged 2.8% per year for 18 months and decreased to 0.9% each year after. The authors speculated that graft expansion may contribute to recurrent AI after aortic valve reimplantation procedures, and choice of graft size may need to be reduced accordingly.

The behavior of grafts external to the arterial blood flow is not as well studied. Grafts exterior to the circulation have been used as preventive wraps around small aneurysms [15]. In one large series in which Dacron mesh was used to band ascending aortic aneurysms, the mean increase in diameter was 2.6 mm, or 8%, over 5.7 years [22]. Mesh is probably more prone to stretching than tube grafts, and the extent of expansion of periaortic Dacron tube grafts in extravascular locations remains unknown. The present sleeve series used as baseline the aortic diameter measured by TTE at mean 6.8 ± 1.2 days postoperatively and would have missed the initial rapid expansion that was observed [21]. The mean manufacturer's recorded size for the 18 grafts used in the study group was 32.3 mm compared with the sinotubular junction size of 36.9 ± 5.9 mm measured by ultrasound 1 week postoperatively, an expansion of about 4.6 mm or 14%. Ultrasound measurements of large abdominal aortic aneurysms have been shown to overestimate aortic diameter by as much as 5 mm [23], but it is equally likely our measurements just confirm the Etz and colleagues' [21] finding of the early 17% expansion of Dacron tubes within 7 days of implantation in the thoracic aorta. Similar to this study, Etz and colleagues used the manufacturer's listed graft size as the baseline for comparison over time.

Although the degree of expansion of the sleeve graft that resides outside of the central circulation is not known, the possibility of worsening AI due to lateral displacement of the leaflets from graft expansion requires close follow-up. Postoperative AI after the sleeve repair is uniformly central jet, and this may reflect simple graft expansion as has been speculated [21]. If early graft expansion is found to cause the mild trend toward increasing AI at 3 years in this series, it may be necessary to downsize the sleeve graft to equalize the observed 14% initial expansion in this series. The absence of an increase of LVEDD suggests this low-grade postoperative AI is not physiologically detrimental, but a completely competent valve should be obtainable.

A few isolated cases are reported in which the aortic wall inside a tightly wrapped external Dacron graft has become thin and attenuated [24] or ruptured [25], but large, long-term follow-up studies of external Dacron wraps for aneurysms have not found this to be a problem [15].

Use of the Valsalva-design graft appears to be a prudent modification to our original Florida sleeve article [10]; theoretically promoting sinus expansion, improving coronary blood flow, and decreasing leaflet stresses [13, 26, 27]. The results of clinical reports after root remodeling and valve reimplantation procedures have been extensively reviewed [28], and surgeons and engineers have developed models demonstrating increased stresses on aortic leaflets when physiologic sinus and ascending aortic pulsatile expansion is decreased or eliminated [29, 30]. It is generally accepted that the Windkessel effect of the ascending aorta and the natural expansion of the sinuses absorbs some of the force placed on the aortic leaflets during diastole, functionally providing recoil like an elastic reservoir [31]. The sleeve procedure retains the aortic sinuses, but the rigid Dacron sleeve may minimize the benefit of sinus expansion.

Limitations
A major consideration in the interpretation of postoperative echocardiographic dimensions in this series is the unknown contribution of pharmacologic unloading after valve repair. Long-term data about patient medications were not sufficiently available to assess the possible contribution of vasodilators and sympathetic suppression on the improvement of LV geometry in this study. Vasodilators may be immediately effective for the reduction of pulmonary congestion in acute AI, but considerable evidence shows that common vasodilators such as nifedipine, enalapril, or hydralazine are no more effective than placebo in preventing the chronic progression of LV failure in patients with isolated AI [32]. Carabello [33] has also emphasized the lack of data supporting vasodilators in the prevention of LV dysfunction in chronic aortic regurgitation, and no drug combination has been proved to delay the need for valve replacement or to affect morbidity or mortality in chronic AI [34]. The benefit of β-blockers in isolated AI is even less well confirmed [35]. It is probably reasonable to assume the improvement and maintenance of LV dimensions in the sleeve study group is due mainly to a durable valve repair.

Conclusion
The Florida sleeve procedure for valve-sparing correction of functional type I AI associated with aortic root aneurysms is dimensionally stable for at least 2 years. A minor increase in AI between the first and second postoperative years warrants continued close follow-up. The preservation of LVEDD for 3 years after repair is encouraging and supports the continued use of this procedure in closely monitored series. The lesser complexity of the Florida sleeve repair compared with other reimplantation procedures remains an incentive for continued clinical investigation.


    Discussion
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 Discussion
 References
 
DR NEAL D. KON (Winston-Salem, NC): Excellent results and a beautifully presented paper, Dr Martin, and I enjoyed listening to it and reading the manuscript before.

Aortic valve repair and replacement of the aortic sinuses in patients with aortic root aneurysms is a challenging and gratifying procedure. The technical demands of these repairs have challenged many surgeons and, as a result, many times a perfectly good aortic valve is thrown away and a valved conduit is put in place despite a normal aortic valve. A technically simpler approach with predictable results would make valve-sparing procedures more popular and thus the reason that, Tom, you developed the Florida sleeve operation.

Preservation of the native aortic valve requires predictable reduction of the aortic annulus, the sinuses of Valsalva, and, of course, the sinotubular junction. Reduction of each of these structures has to result in a sufficient zone of coaptation for the leaflets, and you appear to be accomplishing that.

Myself, to accomplish these stable reductions, I have used the Stanford modification of the David V operation with good reproducible results. To me, the advantages include fabulous exposure of all of these structures that you have to reduce, the ability to rebuild the aortic root as you go, and, most importantly, the impressive normal 4D [four-dimensional] MRI [magnetic resonance imaging] profiles demonstrated by Dr Miller at Stanford.

I have a few questions for you. First, have you tried other methods of aortic valve repair when fixing aortic root aneurysms? Did you encounter difficulties? Specifically, what were they and what made you think to develop this particular procedure?

I looked at your manuscript and you had a picture of the operation, and you use only 4 sutures in the aortic annulus. And the concept that many aortic root surgeons have is that it is the fibrous portion of the aortic annulus that dilates and not the muscular portion, and therefore, you can selectively reduce the fibrous portion for what we would hope would be a good long-term result. Tell me what you think about that and your opinion.

Also, handling the coronary arteries, I have mobilized a lot of aortic roots and always do it with the coronaries mobilized and then the root beneath mobilized, and it seems difficult to me conceptually to have the area between, for instance, the left coronary artery and the annulus sufficiently mobilized to get the graft around there well. So could you tell us some of the tricks of that.

And finally, to follow on a theme that Dr Cameron started, I quibble with the name, Florida sleeve. I am from the University of Florida, I don't live in Florida anymore, and I am part of the Gator Nation. Now, gator is a way better name for this because a gator goes from the ears to the shoulders, it is circular, and it looks a lot more like an aortic root than a sleeve. So how about considering changing the name?

DR MARTIN: Thank you for your discussion, Dr Kon. The first question is have we tried other methods? Yes. We did about 50 David procedures. We did David Is and David IIs. We never made it to the David V. And, yes, we did find that somewhat of a daunting task. We had good results. I am an Aggie. I am from Texas, I am from Texas A and M. I found that I was measuring, getting my ruler out and doing all those measurements and calculations, and then I would always listen to Kevin Accola, who is standing back there, and I would throw out those numbers and I would get a 30 graft, and then we were putting in a straight tube. It was actually, we thought, a rather difficult procedure, and the whole reason that we tried to come up with something different was to hopefully create something a little bit easier for the surgeon to be able to do, that maybe everyone in this room could do, and more valves would be salvaged. The David procedures were outstanding procedures. If you know how to do them and you get good results, by all means, keep doing them. Our pediatric surgeon at the University of Florida still does Davids, and I have gotten him to do one sleeve, only because he had to. So, yes, we did try those and that is why we did it.

As to the number of sutures, we began in the beginning using 10–12 sutures, I mean, circumferential sutures just like a David because that is what we were used to doing. What we rapidly realized was that we really didn't need those. A large percentage of the patients we were doing these operations on did not have dilated annuluses. We certainly didn't need them on the muscular portion. In trying to maintain that circumferential suture line at the bottom, we actually had a fairly high rate of heart block, which is purely technical. And so we began using less and less sutures. If we have a normal annulus, and I consider a normal annulus to be 26 mm or under, then we may narrow that annulus only about 1 to 2 mm, somewhere in the 24-mm range, with a Hagar dilator in the middle. We use typically 4 to 6 sutures, and if the annulus is dilated at all, we put more sutures along the fibrous portion in order to narrow the fibrous portion. Again, the majority of these patients do not have dilated annuluses and really don't need a whole lot except to anchor the graft.

In terms of the coronary mobilization, I think if you tried it you would find it is really not difficult. You mobilize underneath there, you start on each side, you start and then just dissect down, all the way down, and in the left coronary it is particularly easy. You come around between the aorta and the cava and the dome in the left atrium. You mobilize that area, and you come right to the left main and you can get underneath it. You then come between the aorta and the pulmonary artery, and you dissect down to that aortopulmonary artery fibrous continuity, follow that inferiorly, and it gets right underneath there, put a little right angle underneath there; it works really well, and the right is really pretty easy, very similar.

As to the name, you know, Florida sleeve came up somewhere. I don't know where it came up, but there it is.

DR KEVIN D. ACCOLA (Orlando, FL): Tom, very nice presentation as you all do such a great job up there with all your aortic work. Two questions real quick. One, is there any sinotubular junction size or sinus of Valsalva aneurysm size or is there discrepancy of the sinus of Valsalva that would be prohibitive to do this procedure? In other words, any anatomy that would make you do something different?

Two, you didn't mention anything about the bicuspid valve, which we have had numerous discussions about before, but I am curious if this has changed or altered your management of the bicuspid valve? Thank you.

DR MARTIN: We have been asked those questions, particularly about the size of the sinuses, and can you really stuff a 6-cm or a 7-cm root into a 32- or 34-mm Valsalva graft? And, yes, you can do it. It doesn't look that pretty when you are doing it, but when you get done, the echos all look good and they look good in the long-term. The only anatomic problems we have had in terms of doing this operation have been patients that have had abnormal coronaries and where the coronaries sit up high. Sometimes the coronaries may ride up, particularly in the Marfans, all the way up above the sinotubular junction, and if they really get high, then we have had to do some modification. In a couple of patients, we have actually reverted back to a David in those procedures.

As to the bicuspid aortic valve, we save bicuspid aortic valves only if the valve leaflets are completely normal and there is no prolapse. I know there are a lot of things you can do, but this is just what we do. We don't save anything other than that. I think in a bicuspid valve you have to remember in many of those the suspension mechanism is completely different than a tricuspid valve, and you can't really pull that sinotubular junction back in and you have to try and maintain a little bit larger sinotubular junction.


    References
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 Discussion
 References
 

  1. de Waroux JLP, Pouleur A, Goffinet C, et al. Functional anatomy of aortic regurgitation. Accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography. Circulation 2007;116(suppl I):I-264-I-269.[Abstract/Free Full Text]
  2. Tornos P, Sambola A, Permanyer-Miralda G, Evangelista A, Gomez Z, Soler-Soler J. Long-term outcome of surgically treated aortic regurgitation. Influence of guideline adherence toward early surgery. J Am Coll Cardiol 2006;47:1012-1017.[Abstract/Free Full Text]
  3. Minakata K, Schaff HV, Zehr KJ, et al. Is repair of aortic valve regurgitation a safe alternative to valve replacement? J Thorac Cardiovasc Surg 2004;127:645-653.[Abstract/Free Full Text]
  4. Yacoub MH, Gehle P, Chandrasekaran V, Birks EJ, Child A, Radley-Smith R. Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root J Thorac Cardiovasc Surg 1998;115:1080-1090.[Abstract/Free Full Text]
  5. David TE, Feindel CM, Webb GD, Colman JM, Armstrong S, Maganti M. Long-term results of aortic valve-sparing operations for aortic root aneurysm J Thorac Cardiovasc Surg 2006;132:347-354.[Abstract/Free Full Text]
  6. Nishimura RA, Carabello BA, Faxon DP, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease J Am Coll Cardiol 2008;52:e1-e142.[Free Full Text]
  7. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999;99:1851-1857.[Abstract/Free Full Text]
  8. de Oliveira NC, David TE, Ivanov J, et al. Results of surgery for aortic root aneurysm in patients with Marfan syndrome J Thorac Cardiovasc Surg 2003;125:789-796.[Abstract/Free Full Text]
  9. Bethea BT, Fitton TP, Alejo DE, et al. Results of aortic valve-sparing operations: experience with remodeling and reimplantation procedures in 65 patients Ann Thorac Surg 2004;78:767-772.[Abstract/Free Full Text]
  10. Hess PJ, Klodell CT, Beaver TM, Martin TD. The Florida sleeve: a new technique for aortic root remodeling with preservation of the aortic valve and sinuses Ann Thorac Surg 2005;80:748-750.[Abstract/Free Full Text]
  11. Langer F, Graeter T, Nikoloudakis N, Aicher D, Wendler O, Schäfers HJ. Valve preserving aortic replacement: does the additional repair of leaflet prolapse adversely affect the results? J Thorac Cardiovasc Surg 2001;122:270-277.[Abstract/Free Full Text]
  12. de Kerchove LA, Glineur D, Poncelet A, et al. Repair of aortic leaflet prolapse: a ten year experience Eur J Cardiothorac Surg 2008;34:785-791.[Abstract/Free Full Text]
  13. El Khoury G, Glineur D, Rubay J, et al. Functional classification of aortic root/valve abnormalities and their correlation with etiologies and surgical procedures. Curr Opin Cardiol 20:115–21.
  14. Maselli D, Borelli G, Amerini A, et al. The ideal theoretical graft oversizing in valvesparing aortic operations with a standard tubular or a Valsalva graft Eur J Cardiothorac Surg 2005;28:845-849.[Abstract/Free Full Text]
  15. Robicsek F. A new method to treat fusiform aneurysms of the ascending aorta associated with aortic valve disease: an alternative to radical resection Ann Thorac Surg 1982;32:92-94.
  16. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome Am J Med Genet 1996;62:417-426.[Medline]
  17. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations Ann Thorac Surg 1996;62:932-935.[Abstract/Free Full Text]
  18. Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions Ann Thorac Surg 2008;85:1490-1495.[Free Full Text]
  19. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation Circulation 2003;108:2432-2438.[Free Full Text]
  20. David TE, Armstrong S, Ivanov J. Aortic valve sparing operations: an update Ann Thorac Surg 1999;67:1840-1842.[Abstract/Free Full Text]
  21. Etz CD, Homann T, Silovitz D, et al. Vascular graft replacement of the ascending and descending aorta: do Dacron grafts grow? Ann Thorac Surg 2007;84:1206-1213.[Abstract/Free Full Text]
  22. Cohen O, Odim J, De La Zerda D, et al. Long-term experience of girdling the ascending aorta with Dacron mesh as definitive treatment for aneurysmal dilation Ann Thorac Surg 2007;83:S780-S784.[Abstract/Free Full Text]
  23. Lederle FA, Wilson SE, Johnson GR, et al. Variability in measurement of abdominal aortic aneurysms J Vasc Surg 1995;21:945-952.[Medline]
  24. Bauer M, Grauhan O, Hetzer R. Dislocated wrap after previous reduction aortoplasty causes erosion of the ascending aorta Ann Thorac Surg 2003;75:583-584.[Abstract/Free Full Text]
  25. Robicsek F, Cook JW, Reames MK, Skipper ER. Size reduction ascending aortoplasty: is it dead or alive? J Thorac Cardiovasc Surg 2004;128:562-570.[Abstract/Free Full Text]
  26. Bellhouse BJ, Bellhouse FH, Reid KG. Fluid mechanics of the aortic root with application to coronary flow Nature 1968;219:1059-1061.[Medline]
  27. Zehr KJ, Thubrikar MJ, Gong GG, Headrick JR, Robicsek F. Clinical introduction of a novel prosthesis for valve-preserving aortic root reconstruction for annuloaortic ectasia J Thorac Cardiovasc Surg 2000;120:692-698.[Abstract/Free Full Text]
  28. Miller DC. Valve-sparing aortic root replacement in patients with the Marfan syndrome. Editorial. J Thorac Cardiovasc Surg 2003;125:773-778.[Free Full Text]
  29. Thubrikar MJ, Labrosse MR, Zehr KJ, Robicsek F, Gong GG, Fowler BL. Aortic root dilatation may alter the dimensions of the valve leaflets Eur J Cardiothorac Surg 2005;28:850-856.[Abstract/Free Full Text]
  30. Beller CJ, Labrosse MR, Robicsek F, Thubrikar MJ. Quantitative approach to aortic valve-sparing surgery Interact Cardiovasc Thorac Surg 2006;5:526-530.[Abstract/Free Full Text]
  31. Shepard RB. Invited letter concerning: the effect of extraanatomic bypass on aortic input impedance studied in open chest dogs: should the vascular prosthesis be compliant to unload the left ventricle? J Thorac Cardiovasc Surg 1992;104:1175-1178.[Medline]
  32. Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation N Engl J Med 2005;353:1342-1349.[Medline]
  33. Carabello BA. Vasodilators in aortic regurgitation--where is the evidence of their effectiveness? N Engl J Med 2005;353:1400-1402.[Medline]
  34. Bashore TB. Afterload reduction in chronic aortic regurgitation. It sure seems like a good idea. J Am Coll Cardiol 2005;45:1031-1033.[Free Full Text]
  35. Plante E, Lachance D, Champetie S, et al. Benefits of long-term β-blockade in experimental chronic aortic regurgitation Am J Physiol Heart Circ Physiol 2008;294:H1888-H1895.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. E. David, M. Maganti, and S. Armstrong
Aortic root aneurysm: Principles of repair and long-term follow-up
J. Thorac. Cardiovasc. Surg., December 1, 2010; 140(6_suppl): S14 - S19.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. G. Svensson, M. Cooper, L. H. Batizy, and E. R. Nowicki
Simplified David Reimplantation With Reduction of Anular Size and Creation of Artificial Sinuses
Ann. Thorac. Surg., May 1, 2010; 89(5): 1443 - 1447.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Hetzer, T. Komoda, S. Komoda, F. Berger, and M. Huebler
New Aortic Root Remodeling Surgery in Aortic Root Aneurysm
Ann. Thorac. Surg., April 1, 2010; 89(4): 1260 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Izumoto
The Florida Sleeve Repair: Letter 2
Ann. Thorac. Surg., January 1, 2010; 89(1): 343 - 343.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Gamba, M. Merlo, and M. Triggiani
Promising Early Results of Periaortic Root Remodeling With the Valsalva Graft: Letter 1
Ann. Thorac. Surg., January 1, 2010; 89(1): 342 - 343.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. J. Hess Jr, P. K. Harman, C. T. Klodell, T. M. Beaver, C. G. Tribble, and T. D. Martin
Reply
Ann. Thorac. Surg., January 1, 2010; 89(1): 343 - 344.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philip J. Hess, Jr
P. Kent Harman
Charles T. Klodell
Thomas M. Beaver
Marco T. Bologna
Peter Mikhail
Curtis G. Tribble
Tomas D. Martin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hess, P. J.
Right arrow Articles by Martin, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hess, P. J., Jr
Right arrow Articles by Martin, T. D.
Related Collections
Right arrow Great vessels


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS